Clinical Trials Directory

Trials / Completed

CompletedNCT00122889

Effects of Garlic Supplements on Drug Metabolism

Garlic Metabolism and Cytochrome P450 Modulation

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Fred Hutchinson Cancer Center · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study will determine whether garlic supplements affect the way certain drugs are processed in the body.

Detailed description

Garlic supplements, which are often used to lower cholesterol and prevent cancer, are one of the most commonly used herbal products in the United States. However, little is known about the way garlic supplements may interact with prescription medications when used simultaneously. This study will investigate four commonly used garlic supplements: garlic powder with a low content of allicin (a compound with antibacterial properties), garlic powder with a high allicin content, garlic oil, and aged garlic. The effects of these 4 garlic products on the drug-metabolizing enzyme cytochrome P450 (CYP) and a drug transporter, P-glycoprotein (Pgp) will be examined. Participants will be randomly assigned to receive one of the four garlic supplements for 4 weeks. Drug probes of CYP and Pgp will be used to assess the in vivo activities of the substances. On the first day of garlic ingestion, blood collection will occur immediately after participants ingest their garlic supplement and 3, 4, and 6 hours after ingestion. Urine collection will occur immediately after participants' first garlic ingestion and 12, 15, and 72 hours after ingestion. Blood and urine collection will determine the concentration of the drug probes in the body, which will indicate changes in CYP and Pgp. Blood and urine tests will be repeated at the end of the study.

Conditions

Interventions

TypeNameDescription
DRUGGarlic powder with high allicin content
DRUGGarlic powder with low allicin content
DRUGGarlic oil
DRUGAged garlic

Timeline

Start date
2005-07-01
Completion
2009-03-01
First posted
2005-07-22
Last updated
2010-01-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00122889. Inclusion in this directory is not an endorsement.